-
Eyenovia to Present at the American Academy of Optometry’s Annual Meeting
ソース: Nasdaq GlobeNewswire / 21 10 2022 08:00:00 America/New_York
NEW YORK, Oct. 21, 2022 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a pre-commercial ophthalmic technology company developing the Optejet® delivery system for use both in combination with its own drug-device therapeutic programs as well as out-licensing for additional indications, today announced the company will present at the 2022 American Academy of Optometry’s Annual Meeting, which is taking place from October 26-29, 2022, at the at the San Diego Convention Center. Presentation details are below:
2022 American Academy of Optometry Virtual Press Conference
Presentation Title: Eyenovia - The Optejet® Evolving Drug Delivery to Support Optometric Advancement Presenter: Beth Scott, OD, FAAO, VP Regulatory and Medical Affairs Date and Time: Tuesday, October 25, 5:00 pm to 7:00 pm PST Link: Here 2022 American Academy of Optometry Annual Meeting
Paper Title: Aerial Bioburden Monitoring within Optometric Offices during Normal Office Hours Presenting author: Peter Lam, PhD Session:
Date and Time:P-11: Papers: Screening & Public Health on
October 27, 4:00pm PTLocation: Room 29AB About Eyenovia, Inc.
Eyenovia, Inc. (NASDAQ: EYEN) is an ophthalmic pharmaceutical technology company developing a pipeline of microdose array print (MAP™) therapeutics. Eyenovia is currently focused on the late-stage development of microdosed medications for mydriasis, presbyopia and myopia progression. For more information, visit Eyenovia.com.
The Eyenovia Corporate Information slide deck may be found at ir.eyenovia.com/events-and-presentations.
Eyenovia Contact:
Eyenovia, Inc.
John Gandolfo
Chief Financial Officer
jgandolfo@eyenovia.comEyenovia Investor Contact:
Eric Ribner
LifeSci Advisors, LLC
eric@lifesciadvisors.com
(646) 751-4363Eyenovia Media Contact:
Eyenovia, Inc.
Norbert Lowe
Vice President, Commercial Operations
nlowe@eyenovia.com